Fig. 6
From: SLC45A2 drives prostate cancer progression through tumor promotion and immune suppression
SLC45A2 is closely associated with PRAD cell migration. (A) Transwell assays were conducted to assess the migration of DU145 and LNCaP cells after SLC45A2 knockdown (**P < 0.01). (B) Transwell assays were performed to evaluate the migration of DU145 and LNCaP cells following SLC45A2 overexpression (**P < 0.01). (C) Wound-healing assays validate the impact of SLC45A2 knockdown on PRAD cell migration in LNCaP and DU145 cells. (D) Quantification of wound-healing assay results. (E) IHC analysis of differential expression of SLC45A2 in PRAD tissue and adjacent tissues from HPA dataset. (F) Representative immunohistochemistry of PGM5 on PRAD tissue and adjacent tissues.
